Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00405-010-1257-4.

Title:
Upregulation of IGF2 is associated with an acquired resistance for cis-diamminedichloroplatinum in human head and neck squamous cell carcinoma | European Archives of Oto-Rhino-Laryngology
Description:
Ten head and neck squamous cell carcinoma (HNSCC) cell lines that had acquired cis-diamminedichloroplatinum (CDDP) resistance were successfully established by means of in vitro culture with CDDP. Flow cytometry analysis showed the significantly decreased induction of apoptosis after the CDDP treatment in the acquired CDDP-resistant sublines. Among these, RPMI2650CR showed a 9.38-fold increased IC50 in comparison with the parental cell line, RPMI2650. The identification of the resistance-related gene clusters was conducted between RPMI2650CR and RPMI2650 using two distinct microarray platforms. The expressional profiles were quite similar, suggesting that a limited number of genes regulate the acquisition of CDDP resistance. IGF2 was found to be one of the candidates for acquired CDDP-resistance. The introduction of IGF2 into RPMI2650 caused CDDP resistance along with suppression of CDDP-dependent apoptosis. On the other hand, siRNA-mediated knockdown of IGF2 caused reduction of acquired CDDP-resistance in RPMI2650CR. These results demonstrate that expression of IGF2 plays an important and critical role in CDDP resistance in a HNSCC cell line RPMI2650. These findings suggest the possibility for developing a new strategy for treating patients with HNSCC, particularly those with acquired CDDP resistance, by combining CDDP with inhibition of the IGF2 pathway.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {πŸ“š}

  • Education
  • Science
  • Telecommunications

Content Management System {πŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {πŸ’Έ}

We can't figure out the monetization strategy.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {πŸ”}

cancer, article, google, scholar, pubmed, cas, cell, resistance, ogawa, head, neck, igf, horii, cddp, human, gene, acquired, expression, supplementary, material, squamous, carcinoma, furukawa, cells, analysis, research, lines, genes, res, privacy, cookies, content, takenori, shiga, microarray, access, cisplatin, pancreatic, university, school, medicine, japan, pdf, european, publish, search, cisdiamminedichloroplatinum, hnscc, rpmi, profiles,

Topics {βœ’οΈ}

month download article/chapter oto-rhino-laryngology aims resistance-related gene clusters distinct microarray platforms acquired cddp-resistant sublines article european archives sirna-mediated knockdown growth factor receptor author information authors privacy choices/manage cookies growth factor system full article pdf tumor suppressor gene igf2 caused reduction parental cell line biomedical research core hepg2 cells exposed lrp gene expression tohoku university school european economic area differentially expressed genes nihon university school takenori ogawa cdna microarray normal human tissues human pms2l proteins ovarian cancer cells check access article ogawa instant access pancreatic cancer cells advanced laryngeal cancer significantly decreased induction 38-fold increased ic50 m6a modification regulator standard radiation therapy cisplatin-resistant variant antitumor agents shown multimeric activation complex anticancer drug response excellent secretarial assistance academic frontier project related subjects human pancreatic cancer conditions privacy policy chromosome band 11p15 shows reduced expression enhances cisplatin sensitivity van delft jh acquired cddp-resistance

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Upregulation of IGF2 is associated with an acquired resistance for cis-diamminedichloroplatinum in human head and neck squamous cell carcinoma
         description:Ten head and neck squamous cell carcinoma (HNSCC) cell lines that had acquired cis-diamminedichloroplatinum (CDDP) resistance were successfully established by means of in vitro culture with CDDP. Flow cytometry analysis showed the significantly decreased induction of apoptosis after the CDDP treatment in the acquired CDDP-resistant sublines. Among these, RPMI2650CR showed a 9.38-fold increased IC50 in comparison with the parental cell line, RPMI2650. The identification of the resistance-related gene clusters was conducted between RPMI2650CR and RPMI2650 using two distinct microarray platforms. The expressional profiles were quite similar, suggesting that a limited number of genes regulate the acquisition of CDDP resistance. IGF2 was found to be one of the candidates for acquired CDDP-resistance. The introduction of IGF2 into RPMI2650 caused CDDP resistance along with suppression of CDDP-dependent apoptosis. On the other hand, siRNA-mediated knockdown of IGF2 caused reduction of acquired CDDP-resistance in RPMI2650CR. These results demonstrate that expression of IGF2 plays an important and critical role in CDDP resistance in a HNSCC cell line RPMI2650. These findings suggest the possibility for developing a new strategy for treating patients with HNSCC, particularly those with acquired CDDP resistance, by combining CDDP with inhibition of the IGF2 pathway.
         datePublished:2010-05-05T00:00:00Z
         dateModified:2010-05-05T00:00:00Z
         pageStart:1599
         pageEnd:1606
         sameAs:https://doi.org/10.1007/s00405-010-1257-4
         keywords:
            CDDP
            Chemoresistance
            Chemosensitivity
            HNSCC
            IGF2
            Microarray
            Otorhinolaryngology
            Neurosurgery
            Head and Neck Surgery
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00405-010-1257-4/MediaObjects/405_2010_1257_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00405-010-1257-4/MediaObjects/405_2010_1257_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00405-010-1257-4/MediaObjects/405_2010_1257_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00405-010-1257-4/MediaObjects/405_2010_1257_Fig4_HTML.gif
         isPartOf:
            name:European Archives of Oto-Rhino-Laryngology
            issn:
               1434-4726
               0937-4477
            volumeNumber:267
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Takenori Ogawa
               affiliation:
                     name:Tohoku University School of Medicine
                     address:
                        name:Department of Molecular Pathology, Tohoku University School of Medicine, Sendai, Japan
                        type:PostalAddress
                     type:Organization
                     name:Tohoku University School of Medicine
                     address:
                        name:Department of Otolaryngology and Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Kazumi Ogawa
               affiliation:
                     name:Tohoku University School of Medicine
                     address:
                        name:Department of Molecular Pathology, Tohoku University School of Medicine, Sendai, Japan
                        type:PostalAddress
                     type:Organization
                     name:Tohoku University School of Medicine
                     address:
                        name:Department of Otolaryngology and Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kiyoto Shiga
               affiliation:
                     name:Tohoku University School of Medicine
                     address:
                        name:Department of Otolaryngology and Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Toru Furukawa
               affiliation:
                     name:Tohoku University School of Medicine
                     address:
                        name:Department of Molecular Pathology, Tohoku University School of Medicine, Sendai, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hiroki Nagase
               affiliation:
                     name:Nihon University School of Medicine
                     address:
                        name:Division of Cancer Genetics, Department of Advanced Medical Science, Nihon University School of Medicine, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sho Hashimoto
               affiliation:
                     name:Tohoku University School of Medicine
                     address:
                        name:Department of Otolaryngology and Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Toshimitsu Kobayashi
               affiliation:
                     name:Tohoku University School of Medicine
                     address:
                        name:Department of Otolaryngology and Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Akira Horii
               affiliation:
                     name:Tohoku University School of Medicine
                     address:
                        name:Department of Molecular Pathology, Tohoku University School of Medicine, Sendai, Japan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Upregulation of IGF2 is associated with an acquired resistance for cis-diamminedichloroplatinum in human head and neck squamous cell carcinoma
      description:Ten head and neck squamous cell carcinoma (HNSCC) cell lines that had acquired cis-diamminedichloroplatinum (CDDP) resistance were successfully established by means of in vitro culture with CDDP. Flow cytometry analysis showed the significantly decreased induction of apoptosis after the CDDP treatment in the acquired CDDP-resistant sublines. Among these, RPMI2650CR showed a 9.38-fold increased IC50 in comparison with the parental cell line, RPMI2650. The identification of the resistance-related gene clusters was conducted between RPMI2650CR and RPMI2650 using two distinct microarray platforms. The expressional profiles were quite similar, suggesting that a limited number of genes regulate the acquisition of CDDP resistance. IGF2 was found to be one of the candidates for acquired CDDP-resistance. The introduction of IGF2 into RPMI2650 caused CDDP resistance along with suppression of CDDP-dependent apoptosis. On the other hand, siRNA-mediated knockdown of IGF2 caused reduction of acquired CDDP-resistance in RPMI2650CR. These results demonstrate that expression of IGF2 plays an important and critical role in CDDP resistance in a HNSCC cell line RPMI2650. These findings suggest the possibility for developing a new strategy for treating patients with HNSCC, particularly those with acquired CDDP resistance, by combining CDDP with inhibition of the IGF2 pathway.
      datePublished:2010-05-05T00:00:00Z
      dateModified:2010-05-05T00:00:00Z
      pageStart:1599
      pageEnd:1606
      sameAs:https://doi.org/10.1007/s00405-010-1257-4
      keywords:
         CDDP
         Chemoresistance
         Chemosensitivity
         HNSCC
         IGF2
         Microarray
         Otorhinolaryngology
         Neurosurgery
         Head and Neck Surgery
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00405-010-1257-4/MediaObjects/405_2010_1257_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00405-010-1257-4/MediaObjects/405_2010_1257_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00405-010-1257-4/MediaObjects/405_2010_1257_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00405-010-1257-4/MediaObjects/405_2010_1257_Fig4_HTML.gif
      isPartOf:
         name:European Archives of Oto-Rhino-Laryngology
         issn:
            1434-4726
            0937-4477
         volumeNumber:267
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Takenori Ogawa
            affiliation:
                  name:Tohoku University School of Medicine
                  address:
                     name:Department of Molecular Pathology, Tohoku University School of Medicine, Sendai, Japan
                     type:PostalAddress
                  type:Organization
                  name:Tohoku University School of Medicine
                  address:
                     name:Department of Otolaryngology and Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Kazumi Ogawa
            affiliation:
                  name:Tohoku University School of Medicine
                  address:
                     name:Department of Molecular Pathology, Tohoku University School of Medicine, Sendai, Japan
                     type:PostalAddress
                  type:Organization
                  name:Tohoku University School of Medicine
                  address:
                     name:Department of Otolaryngology and Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kiyoto Shiga
            affiliation:
                  name:Tohoku University School of Medicine
                  address:
                     name:Department of Otolaryngology and Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Toru Furukawa
            affiliation:
                  name:Tohoku University School of Medicine
                  address:
                     name:Department of Molecular Pathology, Tohoku University School of Medicine, Sendai, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hiroki Nagase
            affiliation:
                  name:Nihon University School of Medicine
                  address:
                     name:Division of Cancer Genetics, Department of Advanced Medical Science, Nihon University School of Medicine, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sho Hashimoto
            affiliation:
                  name:Tohoku University School of Medicine
                  address:
                     name:Department of Otolaryngology and Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Toshimitsu Kobayashi
            affiliation:
                  name:Tohoku University School of Medicine
                  address:
                     name:Department of Otolaryngology and Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Akira Horii
            affiliation:
                  name:Tohoku University School of Medicine
                  address:
                     name:Department of Molecular Pathology, Tohoku University School of Medicine, Sendai, Japan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:European Archives of Oto-Rhino-Laryngology
      issn:
         1434-4726
         0937-4477
      volumeNumber:267
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Tohoku University School of Medicine
      address:
         name:Department of Molecular Pathology, Tohoku University School of Medicine, Sendai, Japan
         type:PostalAddress
      name:Tohoku University School of Medicine
      address:
         name:Department of Otolaryngology and Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan
         type:PostalAddress
      name:Tohoku University School of Medicine
      address:
         name:Department of Molecular Pathology, Tohoku University School of Medicine, Sendai, Japan
         type:PostalAddress
      name:Tohoku University School of Medicine
      address:
         name:Department of Otolaryngology and Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan
         type:PostalAddress
      name:Tohoku University School of Medicine
      address:
         name:Department of Otolaryngology and Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan
         type:PostalAddress
      name:Tohoku University School of Medicine
      address:
         name:Department of Molecular Pathology, Tohoku University School of Medicine, Sendai, Japan
         type:PostalAddress
      name:Nihon University School of Medicine
      address:
         name:Division of Cancer Genetics, Department of Advanced Medical Science, Nihon University School of Medicine, Tokyo, Japan
         type:PostalAddress
      name:Tohoku University School of Medicine
      address:
         name:Department of Otolaryngology and Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan
         type:PostalAddress
      name:Tohoku University School of Medicine
      address:
         name:Department of Otolaryngology and Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan
         type:PostalAddress
      name:Tohoku University School of Medicine
      address:
         name:Department of Molecular Pathology, Tohoku University School of Medicine, Sendai, Japan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Takenori Ogawa
      affiliation:
            name:Tohoku University School of Medicine
            address:
               name:Department of Molecular Pathology, Tohoku University School of Medicine, Sendai, Japan
               type:PostalAddress
            type:Organization
            name:Tohoku University School of Medicine
            address:
               name:Department of Otolaryngology and Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Kazumi Ogawa
      affiliation:
            name:Tohoku University School of Medicine
            address:
               name:Department of Molecular Pathology, Tohoku University School of Medicine, Sendai, Japan
               type:PostalAddress
            type:Organization
            name:Tohoku University School of Medicine
            address:
               name:Department of Otolaryngology and Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan
               type:PostalAddress
            type:Organization
      name:Kiyoto Shiga
      affiliation:
            name:Tohoku University School of Medicine
            address:
               name:Department of Otolaryngology and Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan
               type:PostalAddress
            type:Organization
      name:Toru Furukawa
      affiliation:
            name:Tohoku University School of Medicine
            address:
               name:Department of Molecular Pathology, Tohoku University School of Medicine, Sendai, Japan
               type:PostalAddress
            type:Organization
      name:Hiroki Nagase
      affiliation:
            name:Nihon University School of Medicine
            address:
               name:Division of Cancer Genetics, Department of Advanced Medical Science, Nihon University School of Medicine, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Sho Hashimoto
      affiliation:
            name:Tohoku University School of Medicine
            address:
               name:Department of Otolaryngology and Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan
               type:PostalAddress
            type:Organization
      name:Toshimitsu Kobayashi
      affiliation:
            name:Tohoku University School of Medicine
            address:
               name:Department of Otolaryngology and Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan
               type:PostalAddress
            type:Organization
      name:Akira Horii
      affiliation:
            name:Tohoku University School of Medicine
            address:
               name:Department of Molecular Pathology, Tohoku University School of Medicine, Sendai, Japan
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Molecular Pathology, Tohoku University School of Medicine, Sendai, Japan
      name:Department of Otolaryngology and Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan
      name:Department of Molecular Pathology, Tohoku University School of Medicine, Sendai, Japan
      name:Department of Otolaryngology and Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan
      name:Department of Otolaryngology and Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan
      name:Department of Molecular Pathology, Tohoku University School of Medicine, Sendai, Japan
      name:Division of Cancer Genetics, Department of Advanced Medical Science, Nihon University School of Medicine, Tokyo, Japan
      name:Department of Otolaryngology and Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan
      name:Department of Otolaryngology and Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan
      name:Department of Molecular Pathology, Tohoku University School of Medicine, Sendai, Japan
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {πŸ”—}(128)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

CDN Services {πŸ“¦}

  • Crossref

4.26s.